Dr Pasupati is an interventional cardiologist specialising in angioplasty and percutaneous interventions for valvular and structural heart disease.He is one of New Zealand's leading cardiologist in structural heart disease. He has mentored many sites internationally and locally in the development of TAVI. Dr Pasupati is the director of structural heart disease & cardiovascular research unit at Waikato hospital. He is also responsible for the governance of the cathlab at Waikato Hospital. His international reputation is founded on testing & developing new devices in structural and coronary disease and is widely published in this area. He is an invited speaker at interventional meetings worldwide. In addition, Sanjeevan sits on the scientific advisory board & steering committee for various device companies. He was instrumental in developing Southern Cross Heart Institute, the country's technologically most advanced cathlab for coronary angiograms, angioplasty, TAVI, Mitraclip and other complex cardiology procedures.

Hiroyuki Nishi is a cardiovascular surgeon and professor of department of cardiovascular surgery at Tokai University Hachioji Hospital. He graduated from Osaka University in 1995 and worked in Melbourne and Brisbane from 2004 to 2007. He is currently one of the councilors of the Japanese Society for Cardiovascular Surgery and the Japanese Association for Thoracic Surgery. He has been involved in minimally invasive cardiac surgery (MICS) as a consultant surgeon for a long time, and has been active in promoting MICS in Japan as a key member of the Japanese Association of Minimally Invasive Cardiac Surgery. He is well versed in MICS in general, and has also performed the world's first stent graft implantation using an aortic angioscopy. He has also published a paper on new postoperative management of cardiovascular surgery using the new diuretic tolvaptan, and on congestive liver failure due to severe heart failure, making him a cardiovascular surgeon with a deep knowledge of the entire field of cardiovascular surgery.

Robert Horvath is an Infectious Diseases Physician and Microbiologist for Queensland Health, based at The Prince Charles Hospital. He is a founding member and co-chair of Infective Endocarditis Queensland (ieQ), founding member and chair of ACE (Australasian Collaboration in Endocarditis) and founding member of QFIG-(national) Q Fever Interest Group.

Dr Dale Murdoch is an interventional cardiologist at The Prince Charles and St Vincent’s Private Hospitals in Brisbane and is a Senior Lecturer in Medicine at The University of Queensland. His interests include transcatheter heart valves and structural heart disease intervention.

David Muller is Professor of Medicine at the University of New South Wales, Director of Interventional Cardiology Services at St Vincent’s Hospital, Sydney, and a faculty member of the Victor Chang Cardiac Research Institute. After graduating from the University of Melbourne, he completed his Advanced Training in Cardiology in Melbourne and Interventional Cardiology Fellowship at the University of Michigan Medical Centre. His current major research interests include transcatheter therapies for structural heart disease, the physiological and haemodynamic responses to transcatheter valve interventions, and optimizing the outcomes of complex coronary interventions. He has published widely (>500 peer reviewed papers, abstracts and book chapters) and is a regular speaker at international Cardiology meetings. He has held leadership roles in multiple international device trials, including first-in-human studies, and has been a member of numerous state and federal government Advisory Committees.

Nelson Alphonso is the Director of Cardiac Surgery at the Queensland Children's Hospital and co-director of Queensland Paediatric Research. He has over 100 publications in paediatric cardiac surgery. He is also the co-founder and Program Manager of the Australia New Zealand Congenital Outcomes Registry for Surgery (ANZCORS).